Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468)

Behzad Mansoori ^1,2, Ali Mohammadi ¹, Samira Goldar ¹, Dariush shanehbandi ¹, Leila Mohammadnejad ¹, Elham Baghbani ¹, Tohid Kazemi ¹, Saeed Kachalaki ¹, Behzad Baradaran ¹ *

Cited by CrossRef: 21

1- Naghizadeh S, Mansoori B, Mohammadi A, Kafil H, Mousavi Z, Sakhinia E, Baradaran B. Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines. J of Cellular Biochemistry. 2019;120(4):5024 [Crossref]

2- Musavi Shenas S, Mansoori B, Mohammadi A, Salehi S, Kaffash B, Talebi B, Babaloo Z, Shanehbandi D, Baradaran B. SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line. Artificial Cells, Nanomedicine, and Biotechnology. 2017;45(5):969 [Crossref]

3- Mohammadi A, Mansoori B, Baradaran B. Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies. Biomedicine & Pharmacotherapy. 2017;86:262 [Crossref]

4- Naghizadeh S, Mansoori B, Mohammadi A, Sakhinia E, Baradaran B. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance. CMC. 2019;26(34):6282 [Crossref]

5- Eslami F, Mahdavi M, Babaei E, Hussen B, Mostafavi H, Shahbazi A, Hidayat H. Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family. Toxicology and Applied Pharmacology. 2020;409:115331 [Crossref]

6- Mansoori B, Mohammadi A, Asadzadeh Z, Shirjang S, Minouei M, Abedi Gaballu F, Shajari N, Kazemi T, Gjerstorff M, Duijf P, Baradaran B. HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancy. Journal Cellular Physiology. 2019;234(10):17714 [Crossref]

7- Majidinia M, Yousefi B. DNA repair and damage pathways in breast cancer development and therapy. DNA Repair. 2017;54:22 [Crossref]

8- Wang Y, Liu Z, Shen J. MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation. Int J Mol Med. 2018; [Crossref]

9- Aghajani M, Mokhtarzadeh A, Aghebati-Maleki L, Mansoori B, Mohammadi A, Safaei S, Asadzadeh Z, Hajiasgharzadeh K, Khaze Shahgoli V, Baradaran B. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Mol Biol Rep. 2020;47(5):3691 [Crossref]

10- Mohammadi A, Mansoori B, Savadi P, khaze V, Minouei M, McMillan N, Hallaj‐Nezhadi S, Baradaran B. Targeting of high mobility group A2 by small interfering RNA‐loaded nanoliposome‐induced apoptosis and migration inhibition in gastrointestinal cancer cells. J of Cellular Biochemistry. 2019;120(6):9203 [Crossref]

11- Razi Soofiyani S, Mohammad Hoseini A, Mohammadi A, Khaze Shahgoli V, Baradaran B, Hejazi M. siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells. Adv Pharm Bull. 2017;7(4):637 [Crossref]

12- Krahn N, Meier M, To V, Booy E, McEleney K, O’Neil J, McKenna S, Patel T, Stetefeld J. Nanoscale Assembly of High-Mobility Group AT-Hook 2 Protein with DNA Replication Fork. Biophysical Journal. 2017;113(12):2609 [Crossref]

13- Mansoori B, Mohammadi A, Naghizadeh S, Gjerstorff M, Shanehbandi D, Shirjang S, Najafi S, Holmskov U, Khaze V, Duijf P, Baradaran B. miR‐330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. Journal Cellular Physiology. 2020;235(2):920 [Crossref]

14- Mohammadi A, Mansoori B, Baradaran B. The role of microRNAs in colorectal cancer. Biomedicine & Pharmacotherapy. 2016;84:705 [Crossref]

15- Kooshkaki O, Derakhshani A, Conradie A, Hemmat N, Barreto S, Baghbanzadeh A, Singh P, Safarpour H, Asadzadeh Z, Najafi S, Brunetti O, Racanelli V, Silvestris N, Baradaran B. Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments. Front Oncol. 2020;10 [Crossref]

16- Salehi S, Mansoori B, Mohammadi A, Davoudian S, Musavi Shenas S, Shajari N, Majidi J, Baradaran B. An analysis of suppressing migratory effect on human urinary bladder cancer cell line by silencing of snail-1. Biomedicine & Pharmacotherapy. 2017;96:545 [Crossref]

17- Mansoori B, Duijf P, Mohammadi A, Najafi S, Roshani E, Shanehbandi D, Hajiasgharzadeh K, Shirjang S, Ditzel H, Kazemi T, Mokhtarzadeh A, Gjerstorff M, Baradaran B. Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opinion on Therapeutic Targets. 2020;24(3):255 [Crossref]

18- Esmailzadeh S, Mansoori B, Mohammadi A, Shanehbandi D, Baradaran B. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma. J Gastrointest Canc. 2017;48(2):156 [Crossref]

19- Jafarlou M, Shanehbandi D, Dehghan P, Mansoori B, Othman F, Baradaran B. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia. Artificial Cells, Nanomedicine, and Biotechnology. 2017;:1 [Crossref]

20- Lotfinejad P, Kazemi T, Safaei S, Amini M, Roshani asl E, Baghbani E, Sandoghchian Shotorbani S, Jadidi Niaragh F, Derakhshani A, Abdoli Shadbad M, Silvestris N, Baradaran B. PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines. Biomedicine & Pharmacotherapy. 2021;138:111436 [Crossref]